Man

Lorna Marisalva Galleguillos Goiry

chief

alemana

santiago, Chile

Líneas de Investigación


currently working on 5 clinical trials regarding new treatments for multiple sclerosis in all phenotypes research on socioeconomical burden and epidemiology of multiple sclerosis research on covid-19 vaccines

Educación

  •  Neuroimmunology, MCGILL UNIVERSITY. Canada, 2013

Experiencia Académica

  •   chief of neuroimmunology Other

    CLINICA ALEMANA

    santiago, Chile

    2014 - A la fecha

  •   associate neurologist Other

    CLINICA DAVILA

    santiago, Chile

    2014 - A la fecha

  •   investigador principal Other

    CLINICA ALEMANA

    centro de ensayos clinicos

    santiago, Chile

    2020 - A la fecha

Experiencia Profesional

  •   neurologist Other

    hospital clinico universidad de chile

    santiago, Chile

    2010 - 2011

  •   neurologist Part Time

    hospital padre hurtado

    santiago, Chile

    2010 - 2011

Formación de Capital Humano


Buenas prácticas clínicas 2022
PPCR, universidad de Harvard 2017


Difusión y Transferencia


no



 

Article (8)

Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America

Contentti, Edgar Carnero; Criniti, Juan; Pettinicchi, Juan Pablo; Cristiano, Edgardo; Patrucco, Liliana; Contreras, Elisa Bribiesca; Gomez-Figueroa, Enrique; Flores-Rivera, Jose; Correa-Diaz, Edgar Patricio; Granda, Ana Maria Toral; et al.

Article ISI
MULTIPLE SCLEROSIS AND RELATED DISORDERS  (2023)

Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors

Carnero Contentti, Edgar; Silva, Berenice; Luetic, Geraldine; Patricio Correa-Diaz, Edgar; Soto de Castillo, Ibis; de Bedoya Hamuy, Fernando Diaz; Gracia, Fernando; Weinshenker, Brian G.

Article ISI
MULTIPLE SCLEROSIS JOURNAL  (2023)

Covid-19 Related Encephalopathy



Article
ARCHIVES OF MEDICAL RESEARCH  (2022)

Monkeypox and Immunosuppressed Neurological Patients: What can we Advise Vaccination in Multiple Sclerosis and Neuromyelitis Optica Patients?

Lorna Galleguillos

Article https://www.jelsciences.com
Journal of Biomedical Research & Environmental Sciences  (2022)

Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis

Soler, Bernardita; Garcia, Lorena; Guzman, Jorge; Jurgensen, Lukas; Guzman, Ignacio; Vera, Francisco; carcamo, claudia

Article ISI
MULTIPLE SCLEROSIS AND RELATED DISORDERS  (2022)

Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America

Ricardo Alonso; Aníbal Chertcoff; Felisa del V Leguizamón; Lorna Galleguillos Goiry; Berenice Silva

Article
Multiple Sclerosis Journal— Experimental, Translational and Clinical  (2021)

Spatial and ecological factors modulate the incidence of anti-NMDAR encephalitis, a systematic review

Agustí Alentorn; Giulia Berzero; Harry Alexopoulos; John Tzartos; Germán Reyes Botero; Sergio Muñiz-Castrillo; Alberto Vogrig; Bastien Joubert; Francisco A García Jiménez; Dagoberto Cabrera-Hemer; et al.

Article
BIOMEDICINE  (2021)

High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries.

Gonzalez M, Lobos L; Castillo F, Galleguillos L; Lopez NC, Michea L.

Article
Hypertension  (2005)

1
CLAUDIA CARCAMO

Profesor Asociado

neurology

PONTIFICIA UNIVERSIDADA CATÓLICA DE CHILE. DEPARTAMENTO DE NEUROLOGÍA

Santiago, Chile

1
Bernardita Soler

Neurologa

Neurología

Complejo Asistencial Hospital Sótero del Río

Santiago, Chile

7
Lorna Galleguillos

chief

neurology

alemana

santiago, Chile

1
Carolina Pelayo

Médico

Neurología

Pontificia Universidad Católica de Chile

SANTIAGO, Chile